U.S. Drug Pricing Reform: How It Will Reshape the Pharmaceutical Landscape and the Role of Competitive Intelligence
Introduction Background Drug pricing reform in the U.S., driven by legislative changes such as the Inflation Reduction Act (IRA) and ongoing policy initiatives, is set to significantly alter the pharmaceutical competitive landscape. These changes will influence market access, pricing strategies,…


























